Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Aldape

Showing results (141-150 of 345) with videos related to

Pageof 35
Sort By:
JAMA Ophthalmology|July 24, 2015
Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAsMichael T Tetzlaff, Jonathan L Curry, Vivian Yin, et al.
Brain Pathology (Zurich, Switzerland)|May 1, 2019
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updatesDavid N Louis, David W Ellison, Daniel J Brat, et al.
Nature Medicine|June 24, 2020
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomesFarshad Nassiri, Ankur Chakravarthy, Shengrui Feng, et al.
Acta Neuropathologica|October 18, 2024
MYB/MYBL1-altered gliomas frequently harbor truncations and non-productive fusions in the MYB and MYBL1 genesHye-Jung Chung, Sharika Rajan, Zhichao Wu, et al.
American Journal of Clinical Pathology|March 13, 2014
Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencingBryce P Portier, Rashmi Kanagal-Shamanna, Rajyalakshmi Luthra, et al.
Journal of Neuro-Oncology|August 22, 2022
The role of methylation profiling in histologically diagnosed neurocytoma: a case seriesAdam Z Kalawi, Denise M Malicki, Zied Abdullaev, et al.
Acta Neuropathologica|September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
Free Neuropathology|November 29, 2023
Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approachDavid E Reuss, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|February 7, 2021
A novel ATXN1-DUX4 fusion expands the spectrum of 'CIC-rearranged sarcoma' of the CNS to include non-CIC alterationsDrew Pratt, Chandan Kumar-Sinha, Marcin Cieślik, et al.
Pageof 35

Showing results (141-150 of 345) with videos related to

Sort By:
Pageof 35
JAMA Ophthalmology|July 24, 2015
Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAsMichael T Tetzlaff, Jonathan L Curry, Vivian Yin, et al.
Brain Pathology (Zurich, Switzerland)|May 1, 2019
cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updatesDavid N Louis, David W Ellison, Daniel J Brat, et al.
Nature Medicine|June 24, 2020
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomesFarshad Nassiri, Ankur Chakravarthy, Shengrui Feng, et al.
Acta Neuropathologica|October 18, 2024
MYB/MYBL1-altered gliomas frequently harbor truncations and non-productive fusions in the MYB and MYBL1 genesHye-Jung Chung, Sharika Rajan, Zhichao Wu, et al.
American Journal of Clinical Pathology|March 13, 2014
Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencingBryce P Portier, Rashmi Kanagal-Shamanna, Rajyalakshmi Luthra, et al.
Journal of Neuro-Oncology|August 22, 2022
The role of methylation profiling in histologically diagnosed neurocytoma: a case seriesAdam Z Kalawi, Denise M Malicki, Zied Abdullaev, et al.
Acta Neuropathologica|September 28, 2018
cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV"Daniel J Brat, Kenneth Aldape, Howard Colman, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
Free Neuropathology|November 29, 2023
Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approachDavid E Reuss, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|February 7, 2021
A novel ATXN1-DUX4 fusion expands the spectrum of 'CIC-rearranged sarcoma' of the CNS to include non-CIC alterationsDrew Pratt, Chandan Kumar-Sinha, Marcin Cieślik, et al.
Pageof 35